Metraipolis › archive › dc_c2fc7d4cbee6
Comparative Protective Effects of Anakinra and Tocilizumab in Experimental Ocular Ischemic Syndrome — Europe PMC PMID:42589680
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42589680
- DOI
- 10.3390/ijms27157029
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T15:01:43.799Z
- SHA-256 of the archived text
54179c6c8847ef43471e179c7c6d0a7239a44f71bc9caee958359f9b02d44dbe- Stable URL of this page
https://metraipolis.com/documento/dc_c2fc7d4cbee6
How to cite
Comparative Protective Effects of Anakinra and Tocilizumab in Experimental Ocular Ischemic Syndrome — Europe PMC PMID:42589680 — Europe PMC (en), https://europepmc.org/article/MED/42589680 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c2fc7d4cbee6 (Metraipolis archive dc_c2fc7d4cbee6, sha256 54179c6c8847ef43471e179c7c6d0a7239a44f71bc9caee958359f9b02d44dbe)
BibTeX
@misc{dcc2fc7d4cbee6,
title = {Comparative Protective Effects of Anakinra and Tocilizumab in Experimental Ocular Ischemic Syndrome — Europe PMC PMID:42589680},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42589680},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c2fc7d4cbee6; sha256 54179c6c8847ef43471e179c7c6d0a7239a44f71bc9caee958359f9b02d44dbe},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42589680. Agents can read the archived copy with the MCP tool read_document.